One of the biggest challenges facing biologic drug developers are varying efficacy and the dangers of side effects.

Elon Musk's brain implant startup, Neuralink, has raised $600 million in a funding round that values the company at $9 billion pre-money, Semafor ...

The University of Virginia Medical Center is not just one of Newsweek’s top 50 hospitals in the country (and No. 1 in the ...

If he’d pursued his first love, Simon Cherry might be unraveling the mysteries of the universe through astronomy instead of ...

A remarkable aspect of this technology is its ability to project entirely different images depending on both the wavelength (color) and spin (polarization direction) of light. For example, ...

Researchers at SKUAST have achieved India's first gene-edited sheep using CRISPR-Cas9 technology. This breakthrough in animal ...

Lawmakers in Iowa, Idaho, Texas, and Kentucky have introduced bills that would ban or restrict vaccines that use messenger ...

Three-quarters of US-based researchers and graduate students are considering working abroad, according to a recent study.

Moving beyond traditional methods of observing thinly sliced and stained cancer tissues, a collaborative international ...

Tadaaki Taniguchi, M.D., Ph.D., Chief Research & Development Officer, Astellas | Astellas’ Chief R&D Officer, Tadaaki ...

Biotechnology has emerged as a driving force in transforming healthcare. Over the past few decades, the integration of biology with advanced technology has led to significant breakthroughs. These ...

Transforming Preclinical Screening with Speed, Precision, and Scalability. Explore How This Model Organism is Shaping the Next Era of Pharmaceutical Innovation. Executive Summary & Key Findings Market ...